What are the causes and base rate of lactic acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes and Base Rate of Lactic Acidosis

Lactic acidosis is primarily classified into Type A (inadequate tissue perfusion/oxygenation) and Type B (other causes), with metformin-associated lactic acidosis being rare at 2-9 cases per 100,000 patients per year. 1

Classification of Lactic Acidosis

Type A Lactic Acidosis (Tissue Hypoxia)

  • Circulatory disorders including shock and cardiac failure leading to inadequate tissue perfusion 1, 2
  • Severe infections and sepsis causing systemic hypoperfusion 1
  • Pulmonary disorders resulting in hypoxemia 2
  • Hemoglobin transfer disorders affecting oxygen delivery to tissues 2

Type B Lactic Acidosis (Non-Hypoxic)

  • Medication-induced, particularly metformin in patients with renal impairment 1, 3
  • Nucleoside reverse transcriptase inhibitors (NRTIs) in HIV treatment, especially stavudine and didanosine 4, 1
  • Liver disease impairing lactate metabolism 2
  • D-lactic acidosis in patients with short bowel syndrome and preserved colon 1
  • Malignancies causing increased glycolysis 2
  • Thiamine deficiency affecting pyruvate dehydrogenase function 2
  • Uncoupling of oxidative phosphorylation 2

Base Rate and Epidemiology

  • Lactic acidosis is the most common form of metabolic acidosis 5
  • Metformin-associated lactic acidosis occurs at a rate of 2-9 cases per 100,000 patients per year 1
  • Incidence is higher in patients with renal impairment, with eGFR <30 mL/min/1.73m² 4, 3
  • Lactic acidosis from metformin is exceedingly rare even in patients with GFR 30-60 mL/min/1.73m² 4
  • In a study of patients with type 2 diabetes and COVID-19, metformin use was associated with increased incidence of lactic acidosis (adjusted hazard ratio 4.46) 4

Diagnostic Criteria

  • Blood lactate levels >2 mmol/L are considered elevated 1
  • Levels >5 mmol/L are considered abnormal 1, 3
  • Levels >10 mmol/L are considered serious/life-threatening 1
  • Arterial pH <7.3 with increased anion gap (>16) 1
  • Metformin-associated lactic acidosis is characterized by elevated blood lactate concentrations (>5 mmol/L), anion gap acidosis, and increased lactate:pyruvate ratio 3

Risk Factors

  • Renal impairment (eGFR <45 mL/min/1.73m²) 4, 3
  • Advanced age (>65 years) 1, 3
  • Liver disease 4, 2
  • Cardiac disease, including congestive heart failure 4, 3
  • Hypoxic conditions 2
  • Sepsis and severe infections 1, 6
  • Concurrent use of medications that impair renal function or increase metformin accumulation 3
  • Radiologic procedures with iodinated contrast in patients on metformin 3
  • Alcohol abuse 4

Clinical Presentation

  • Often presents with nonspecific symptoms including:
    • Gastrointestinal symptoms (nausea, vomiting, abdominal pain) 1, 3
    • Respiratory symptoms (tachypnea, dyspnea) 1
    • Neurological symptoms (weakness, confusion, somnolence) 1, 3
  • Severe cases may present with hypotension and resistant bradyarrhythmias 3
  • In metformin overdose, can present with euglycemic diabetic ketoacidosis 7

Management Principles

  • Discontinuation of offending medications (metformin, NRTIs) 1, 3
  • Treatment of underlying causes (infection, shock, hypoxia) 1, 2
  • Supportive care in a hospital setting 3
  • Hemodialysis for severe metformin-associated lactic acidosis (metformin is dialyzable with clearance up to 170 mL/min) 3
  • Sodium bicarbonate administration is controversial and may increase lactate production 2
  • Early identification and intervention is crucial for improving outcomes 6

Special Considerations

  • Metformin should be discontinued at the time of or prior to iodinated contrast imaging procedures in patients with eGFR between 30-60 mL/min/1.73m² 3
  • The incidence of lactic acidosis in HIV patients has decreased as newer antiretrovirals have replaced older NRTIs like didanosine, stavudine, and zidovudine 4
  • Multiple causes of lactic acidosis may coexist in critically ill patients 8

References

Guideline

Lactic Acidosis Causes and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lactic acidosis update for critical care clinicians.

Journal of the American Society of Nephrology : JASN, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lactic acidosis.

Endocrinology and metabolism clinics of North America, 1993

Research

Lactic Acidosis Related to Pharmacotherapy and Human Diseases.

Pharmaceuticals (Basel, Switzerland), 2022

Research

Lactic Acidosis in a Patient with Type 2 Diabetes Mellitus.

Clinical journal of the American Society of Nephrology : CJASN, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.